Literature DB >> 9027354

The LH/CG and FSH receptors: different molecular forms and intracellular traffic.

M Misrahi1, I Beau, N Ghinea, B Vannier, H Loosfelt, G Meduri, M T Vu Hai, E Milgrom.   

Abstract

Monoclonal antibodies have been raised against the LH/CG receptor [1] and have allowed to perform immunochemical studies of the receptor in target cells. Three different forms of the LH/CG receptor are physiologically expressed: a mature approximately 85 kDa transmembrane species corresponding to the full length receptor, a approximately 68 kDa high mannose containing species corresponding to a precursor which accumulates inside the cells, and truncated soluble approximately 45-48 kDa molecular weight species corresponding to the variant messanger RNAs generated by alternative splicing. Monoclonal antibodies against the human FSH receptor were also prepared. They allow to observe the existence of two forms of the FSH receptor in the ovaries: a major approximately 87 kDa species corresponding to the mature receptor and a minor approximately 81 kDa species corresponding to a high mannose rich precursor. No variant forms of the receptor corresponding to alternative mRNA transcripts were detected. The transport of hCG was examined in rat testicular microvasculature by electron microscopy and by analyzing the transfer of radiolabeled hormone and antireceptor antibodies. LH/CG receptors were present in endothelial cells and were involved in hormone transcytosis through these cells. Immunocytochemical experiments have shown that the FSH receptor has a polarized expression in the Sertoli cells of the testes whereas the LH/Cg receptor is spread on the surface of thecal granulosa and luteal cells in the ovary and Leydig cells in the testes. To study the mechanism of this polarization FSH, LH and TSH receptors were expressed in polarized MDCK cells. The mechanism of basolateral localization and of transcytosis of the receptors was studied using this model. The effect of hormone, cAMP and agents acting on G proteins was examined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027354     DOI: 10.1016/s0303-7207(96)03953-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

Review 1.  Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?

Authors:  Konstantinos Papadimitriou; Panteleimon Kountourakis; Anastasia E Kottorou; Anna G Antonacopoulou; Christian Rolfo; Marc Peeters; Haralabos P Kalofonos
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 2.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

3.  Regulation of Endothelial Permeability in the Corpus Luteum: A Review of the Literature.

Authors:  D Herr; I Bekes; C Wulff
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-11       Impact factor: 2.915

4.  Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors.

Authors:  S Brouillet; P Hoffmann; S Chauvet; A Salomon; S Chamboredon; F Sergent; M Benharouga; J J Feige; N Alfaidy
Journal:  Cell Mol Life Sci       Date:  2011-12-03       Impact factor: 9.261

5.  Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function.

Authors:  Hirokazu Matsumura; Kiyoshi Kano; Caralina Marín de Evsikova; James A Young; Patsy M Nishina; Jürgen K Naggert; Kunihiko Naito
Journal:  Physiol Genomics       Date:  2009-08-11       Impact factor: 3.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.